Showing results (51-60 of 248) with videos related to
Sort By:
Pageof 25
Drugs of Today (Barcelona, Spain : 1998)|February 13, 2003
Nonplatelet-mediated effects of aspirinY Wady Aude, J L MehtaBiochemical Pharmacology|November 15, 1990
Inhibitory effect of unstimulated neutrophils on platelet aggregation by release of a factor similar to endothelium-derived relaxing factor (EDRF)F A Nicolini, J L MehtaJournal of the American College of Cardiology|July 1, 1990
Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevanceJ L Dinerman, J L MehtaThe American Journal of Cardiology|March 1, 1984
Comparative efficacy and safety of lofexidine and clonidine in mild to moderately severe systemic hypertensionL M Lopez, J L MehtaJournal of Cardiovascular Pharmacology|November 1, 1994
Platelet-derived adenosine contributes to the cardioprotective effects of platelets against ischemia-reperfusion injury in isolated rat heartB C Yang, J L MehtaThe American Journal of Physiology|March 1, 1995
Critical role of endothelium in sustained arterial contraction during prolonged hypoxiaB C Yang, J L MehtaLife Sciences|January 1, 1994
Inhibitory effect of high-density lipoprotein on platelet function is mediated by increase in nitric oxide synthase activity in plateletsL Y Chen, J L MehtaLife Sciences|January 1, 1997
Inhibition of nitric oxide does not affect reperfusion-induced myocardial injury, but it prevents lipid peroxidation in the isolated rat heartB C Yang, J L MehtaJournal of Cardiovascular Pharmacology|July 24, 1998
Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet functionL Y Chen, J L MehtaThe Journal of Laboratory and Clinical Medicine|March 1, 1996
Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human plateletsJ L Mehta, L Y ChenPageof 25